References (1) Robert A. Weinberg. How Cancer Arises ,An Explosion of Research is Uncovering the Long- Hidden Molecular Underpinnings of Cancer-and Suggesting New Therapies. Sci. Am. 1996 , 62–68. (2) Beale, J. M.; John H. Block. Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry , 12th Editi.; David B. Troy, Ed.; Wolters Kluwer health, 2011. (3) Myles, A.; Penselau, C.; Friedman, O. M. Synthesis of Aldophosphamide, A Key Cyclophosphamide Metabolites. Tetrahedron Lett. 1977 , No. 29, 2475–2478. (4 ) Alagarsamy, V. Textbook of Medicinal Chemistry, Volume II ; 2010. (5) Singh, R. K.; Prasad, D. N.; Bhardwaj, T. R. Design, Synthesis, Chemical and Biological Evaluation of Brain Targeted Alkylating Agent Using Reversible Redox Prodrug Approach. Arab. J. Chem. 2017 , 10 (3), 420–429. (6) Ashutosh Kar. Medicinal Chemistry , fourth.; New Age International (P) Ltd.: New Delhi- 110002, 2007. (7) Iradyan, M. A.; Iradyan, N. S.; Stepanyan, G. M.; Arsenyan, F. G.; Garibdzhanyan, B. T. Antitumor Activity of Imidazole Derivatives: Dacarbazine and the New Alkylating Agent Imidazene (Review). Pharm. Chem. J. 2010 , 44 (4), 175–182. (8) Wanner, M. J.; Koomen, G.-J. A New Synthesis of Temozolomide. J. Chem. Soc. Perkin Trans. 1 2002 , 4 (16), 1877–1880. (9) Chand, M.; Shukla, A. Novel Synthesis of Altretamine and Their Process Impurities Using Imidazolium Type of Ionic Liquids. 1–9. (10) https://www.cancer.gov/about-cancer/understanding/what-is-cancer/types of cancer 29